Literature DB >> 19056047

Surgical management of von Hippel-Lindau disease: urologic considerations.

Amanda Beth Reed1, Dipen J Parekh.   

Abstract

Von Hippel-Lindau (VHL) disease is an autosomal dominant inherited tumor syndrome in which a genetic defect in the VHL gene is located on chromosome 3p25. The urologic surgeon is an integral part of the management team for patients who have VHL disease, because patients frequently have multiple urologic tumors. This article presents a cumulative review of the literature regarding the diagnosis and management of urologic tumors in patients who have VHL disease, along with the latest data regarding the genetics and molecular mechanisms of VHL disease.

Entities:  

Mesh:

Year:  2009        PMID: 19056047     DOI: 10.1016/j.soc.2008.08.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  3 in total

1.  Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.

Authors:  Taekmin Kwon; In Gab Jeong; Sahyun Pak; Dalsan You; Cheryn Song; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

2.  Invasive management of renal cell carcinoma in von Hippel-Lindau disease.

Authors:  Diego M Carrion; Estefanía Linares-Espinós; Emilio Ríos González; Alfredo Aguilera Bazán; Mario Alvarez-Maestro; Luis Martinez-Pineiro
Journal:  Cent European J Urol       Date:  2020-05-20

3.  Radioactive seed localization of renal cell carcinoma in a patient with Von Hippel-Lindau disease.

Authors:  Christina Marie Schiøttz Hassing; Tove Filtenborg Tvedskov; Niels Kroman; Thomas Levin Klausen; Sissal Djurhuus; Linnea Langhans
Journal:  Clin Case Rep       Date:  2016-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.